drugset / Trial / NCT01111045

Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

NCT01111045

Phase 2 Completed 355 enrolled Stryker Biotech
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of the study are to evaluate the safety and efficacy of intraarticular BMP-7 for the treatment of osteoarthritis of the knee.

Timeline

Start
2010-04
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bone morphogenetic protein 7 Unknown 0.03 mg/ml Other
Comparator Bone morphogenetic protein 7 Unknown 0.1 mg/ml Other
Comparator Bone morphogenetic protein 7 Unknown 0.3 mg/ml Other

Indications